Telepsychiatry platform Alma has raised USD 130 million in a Series D funding round led by Thoma Bravo with participation from Cigna Ventures and other venture capital firms. This brings the total funding raised by the company to over USD 220 million and the latest round is estimated to value Alma at approximately USD 800 million.
The funds will be used to expand the company’s geographic footprint across the US.
Post funding, the company will on-board a new Vice President of Clinical Operations, Chief Product Officer, and General Counsel. These roles will be undertaken by Dr. Elisabeth Morray (former head of LifeStance), Erik Lumer (former Chief Product Officer at Maven Clinic), and Chiddy Onyia, Esq. (former General Counsel and Chief Compliance Officer at Quartet Health) respectively.
Over the last year, Alma has increased its network of licensed mental healthcare providers across the US to 8,000 providers (up 3x YoY), covering over 40 languages
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.